Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
6
self-reported 2–10 band
Founded
2021
5 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
1
Grant · Jul 2025 · US$ 485.2K
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
NANOMEDX PTY LTD
ABN89662910214
Legal entities
Show as table · Nanomedx: 1 registry entity
| NANOMEDX PTY LTD | ABN 89662910214 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Nanomedx has developed a novel carbon-based nanoparticle which can be utilised for multiple clinical applications to address some of the most pressing challenges in modern medicine. The Nanomedx platform is built on the scientific discovery of Professor Steven Wise and his team at University of Sydney. The technology and the associated IP has been further researched and adapted for clinical applications at the Heart Research Institute (HRI) in Sydney and has received funding from the National Foundation for Medical Research and Innovation (NFMRI) and the Targeted Translation Research Accelerator (TTRA). Nanomedx has a clear objective of establishing itself as the global leader in medical nanoparticle technology and ensuring that the myriad therapies developed on the back of the platform will result in unprecedented clinical benefits for patients around the world.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUCharles Perkins Centre; University of Sydney; Sydney, NSW 2006Primary
Grid intelligence Members
Funding
Rounds1
Round typeGrant · non-equity funding
Amount (USD)485,200
Stage rank1
Investors named1
Since last round6 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 2021 to 2026 |
| Grant · 20 Jul 2025 | US$ 485.2K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
Which legal entity operates under Nanomedx?
One New South Wales entity on the ABR. NANOMEDX PTY LTD (ABN 89 662 910 214), high confidence.
How many people work at Nanomedx?
The record holds 6 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Nanomedx have offices?
One address on record, Australia only. Primary: Charles Perkins Centre, University of Sydney, Sydney, NSW 2006.
Has Nanomedx raised funding?
One round. Latest 20 July 2025: grant, US$485,200, investor MTPConnect.
Which companies are listed alongside Nanomedx?
9 profiles list Nanomedx as a peer — 86th percentile in Medical Equipment Manufacturing. It lists ten peers of its own. Theia Medical Pty Ltd and Anaxis Pharma list it back.